Prognostic significance of interleukin-6 measurement in the diagnosis of acute myocardial infarction in emergency department

Clinica Chimica Acta

Volumn 381, Issue 2, 2007, Pages 151-156

  Ferroni, Patrizia ^a   Rosa, Antonello ^b   Di Franco, Manuela ^b   Palmirotta, Raffaele ^a   Guadagni, Fiorella ^a   Davì, Giovanni ^c   Bertazzoni, Giuliano ^b   Basili, Stefania ^b  

^a IRCCS SAN RAFFAELE PISANA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF CHIETI   (Italy)

Author keywords

Inflammation; Interleukin 6; Myocardial infarction

Indexed keywords

C REACTIVE PROTEIN; CREATINE KINASE; INTERLEUKIN 6;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST; DYSPNEA; EMERGENCY WARD; FEMALE; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL COUNT; PRECORDIAL PAIN; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SENSITIVITY AND SPECIFICITY; UNSTABLE ANGINA PECTORIS;

ACUTE DISEASE; ACUTE-PHASE REACTION; AGED; ANGINA, UNSTABLE; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHEST PAIN; CREATINE KINASE, MB FORM; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; INTERLEUKIN-6; LIVER; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOGLOBIN; PILOT PROJECTS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK ASSESSMENT; TROPONIN I;

ANGINA;

EID: 34248193700     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2007.03.002     Document Type: Article

References (39)

1. Kendrick S., Frame S., and Povey C. Beds occupied by emergency patients: long term trends in patterns of short term fluctuations in Scotland. Health Bull (Edinb) 55 (1997) 167-175
2. Blatchford O., and Capewell S. Emergency medical admission in Glasgow: general practices vary despite adjustment for age, sex and deprivation. Br J Gen Pract 49 (1999) 551-554
3. Capewell S., and McMurray J. "Chest-pain-please admit": is there an alternative?. Br Med J 320 (2000) 951-952
4. Lee T.H., Rouan G.W., Weisberg M.C., et al. Clinical characteristics and natural history of patients with acute myocardial infarction sent home from the emergency room. Am J Cardiol 60 (1987) 219-224
5. Ryan T.J., Antman E.M., Brooks L.H., et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol 34 (1999) 890-911
6. Lee T.H., Rouan G.W., Weisberg M.C., et al. Sensitivity of routine clinical criteria for diagnosing myocardial infarction within 24 hours of hospitalization. Ann Intern Med 106 (1987) 181-186
7. Zimmerman J., Fromm R., Meyer D., et al. Diagnostic marker cooperative study for the diagnosis of myocardial infarction. Circulation 99 (1999) 1671-1677
8. Sonel A., Sasseen Brett M., Fineberg N., et al. Prospective study correlating fibrinopeptide A, troponin I, myoglobin, and myosin light chain levels with early and late ischemic events in consecutive patients presenting to the emergency department with chest pain. Circulation 102 (2000) 1107-1113
9. Kaeng W.L., Blann A.D., and Lip G.Y.H. Plasma markers of endothelial damage/dysfunction, inflammation and thrombogenesis in relation to TIMI risk stratification in acute coronary syndromes. Thromb Haemost 94 (2005) 1077-1083
10. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 340 (1999) 115-126
11. Ridker P.M., Buring J.E., Shih J., et al. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 98 (1998) 731-733
12. Van Lente F. Markers of inflammation as predictors in cardiovascular disease. Clin Chim Acta 293 (2000) 31-52
13. Morrow D.A., Rifai N., Antman E.M., et al. C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI IIA substudy. J Am Coll Cardiol 31 (1998) 1460-1465
14. Rebuzzi A.G., Quaranta G., Liuzzo G., et al. Incremental prognostic value of serum levels of troponin T and C-reactive protein on admission in patients with unstable angina pectoris. Am J Cardiol 82 (1998) 715-719
15. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28 (1979) 1039-1057
16. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med 153 (1993) 154-183
17. WHO memorandum. Classification of hyperlipidemias and hyperlipoproteinemias. Circulation 1972; 45:501-508.
18. Alpert J.S., Thygesen K., Antman E., et al. Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 36 (2000) 959-969
19. Braunwald E., Antman E.M., Beasley J.W., et al. American College of Cardiology; American Heart Association. Committee on the Management of Patients With Unstable Angina. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction - summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol 40 (2002) 1366-1374
20. Yarnell J.W., Baker I.A., Sweetnam P.M., et al. Fibrinogen, viscosity, and white blood cell count are major risk for ischemic heart disease: the Caerphilly and Speedwell collaborative heart disease studies. Circulation 83 (1991) 836-844
21. Lowe G.D., Machado S.G., Krol W.F., et al. White blood cell count and haematocrit as predictors of coronary recurrence after myocardial infarction. Thromb Haemost 54 (1985) 700-703
22. Ernst E., Hammerschmidt D.E., Bagge U., et al. Leukocytes and the risk of ischemic diseases. JAMA 257 (1987) 2318-2324
23. Burr M.L., Holliday R.M., Fehily A.M., et al. Haematological prognostic indices after myocardial infarction: from the Diet and Reinfarction Trial (DART). Eur Heart J 13 (1992) 166-170
24. Furman M.I., Becker R.C., Yarzebski J., et al. Effect of elevated leukocyte count on in-hospital mortality following acute myocardial infarction. Am J Cardiol 78 (1996) 945-948
25. Barron H.V., Cannon C.P., Murphy S.A., et al. Association between white blood cell count, epicardial blood flow, myocardial perfusion, and clinical outcomes in the setting of acute myocardial infarction: a thrombolysis in myocardial infarction 10 substudy. Circulation 102 (2000) 2329-2334
26. Lowe G.D.O., Woodward M., Rumley A., et al. Association of plasma fibrinogen assay, C-reactive protein and interleukin-6 with previous myocardial infarction. J Thromb Haemost 1 (2003) 2312-2316
27. Beckman J.A., Preis O., Ridker P.M., et al. Comparison of usefulness of inflammatory markers in patients with versus without peripheral arterial disease in predicting adverse cardiovascular outcomes (Myocardial Infarction, Stroke, and Death). Am J Cardiol 96 (2005) 1374-1378
28. Tousoulis D., Antoniades C., Bosinakou E., et al. Differences in inflammatory and thrombotic markers between unstable angina and acute myocardial infarction. Int J Cardiol 115 (2007) 203-207
29. Hartford M., Wiklund O., Mattsson Hultén L., et al. CRP, interleukin-6, secretory phospholipase A2 group IIA, and intercellular adhesion molecule-1 during the early phase of acute coronary syndromes and long-term follow-up. Int J Cardiol 108 (2006) 55-62
30. Lowe G.D.O., Yarnell J.W., Rumley A., et al. C-reactive protein, fibrin D-dimer, and incident ischemic heart disease in the Speedwell study: are inflammation and fibrin turnover linked in pathogenesis?. Arterioscler Thromb Vasc Biol 21 (2001) 603-610
31. Danesh J., Whincup P., Walker M., et al. Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis. BMJ 321 (2000) 208-213
32. Mendall M.A., Strachan D.P., Butland B.K., et al. C-reactive protein: relation to total mortality, cardiovascular mortality and cardiovascular risk factors in men. Eur Heart J 21 (2000) 1584-1590
33. Ridker P.M., Rifai N., Pfeffer M., et al. Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation 101 (2000) 2149-2153
34. Ott I., Neumann F.J., Kenngott S., et al. Procoagulant inflammatory responses of monocytes after direct balloon angioplasty in acute myocardial infarction. Am J Cardiol 82 (1998) 938-942
35. Mann D.L., and Young J.B. Basic mechanisms in congestive heart failure: recognizing the role of proinflammatory cytokines. Chest 105 (1994) 897-904
36. Marx N., Neumann F.J., Ott I., et al. Induction of cytokine expression in leukocytes in acute myocardial infarction. J Am Coll Cardiol 30 (1997) 165-170
37. Neumann F.J., Ott I., Gawaz M., et al. Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation 92 (1995) 748-755
38. Neumann F.J., Ott I., Marx N., et al. Effect of recombinant human interleukin-6 and interleukin-8 on monocyte procoagulant activity. Arterioscler Thromb Vasc Biol 17 (1998) 3399-3405
39. Kempf K., Haltern G., Futh R., et al. Increased TNF-alpha and decreased TGF-beta expression in peripheral blood leukocytes after acute myocardial infarction. Horm Metab Res 38 (2006) 346-351